{"title":"Effect of crosslinking densities on decanoyl-group modified Alaska pollock gelatin microparticles as tissue-adhesive hemostatic powders","authors":"Hatsune Nishino , Shima Ito , Hiyori Komatsu , Satsuki Minamisakamoto , Yasuko Kobayashi , Shiharu Watanabe , Akihiro Nishiguchi , Tetsushi Taguchi","doi":"10.1016/j.bioadv.2025.214534","DOIUrl":null,"url":null,"abstract":"<div><div>Endoscopic submucosal dissection (ESD) is widely utilized as a minimally invasive treatment for early-stage gastrointestinal cancers. However, bleeding after ESD remains a major challenge. This clinical problem necessitates biomaterials with tissue-adhesive and hemostatic properties. Recently, we developed decanoyl group-modified Alaska pollock gelatin microparticles (C10-MPs) as tissue-adhesive hemostatic powders. Dried C10-MPs adhered to and formed colloidal gels on the gastrointestinal tissue surface and demonstrated excellent hemostatic properties. However, the effect of crosslinking density on tissue adhesion and hemostatic properties has not yet been clarified. Herein, we investigated the effect of the crosslinking density on C10-MPs' performance as tissue-adhesive hemostatic powders. C10-MPs with different crosslinking densities were prepared by varying the thermal crosslinking time. All C10-MPs with different crosslinking densities exhibited rapid hydration. Additionally, C10-MPs with higher crosslinking densities exhibited increased adhesion strength and underwater adhesion stability, even in moist environments. Contrastingly, <em>in vitro</em> and <em>in vivo</em> hemostatic evaluation models showed that C10-MPs thermally crosslinked for 5 h (C10 5 h) were the most suitable powder in terms of blood coagulation ability. Thus, C10 5 h has great potential for use in preventing post-ESD bleeding.</div></div>","PeriodicalId":51111,"journal":{"name":"Materials Science & Engineering C-Materials for Biological Applications","volume":"180 ","pages":"Article 214534"},"PeriodicalIF":6.0000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materials Science & Engineering C-Materials for Biological Applications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772950825003619","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Endoscopic submucosal dissection (ESD) is widely utilized as a minimally invasive treatment for early-stage gastrointestinal cancers. However, bleeding after ESD remains a major challenge. This clinical problem necessitates biomaterials with tissue-adhesive and hemostatic properties. Recently, we developed decanoyl group-modified Alaska pollock gelatin microparticles (C10-MPs) as tissue-adhesive hemostatic powders. Dried C10-MPs adhered to and formed colloidal gels on the gastrointestinal tissue surface and demonstrated excellent hemostatic properties. However, the effect of crosslinking density on tissue adhesion and hemostatic properties has not yet been clarified. Herein, we investigated the effect of the crosslinking density on C10-MPs' performance as tissue-adhesive hemostatic powders. C10-MPs with different crosslinking densities were prepared by varying the thermal crosslinking time. All C10-MPs with different crosslinking densities exhibited rapid hydration. Additionally, C10-MPs with higher crosslinking densities exhibited increased adhesion strength and underwater adhesion stability, even in moist environments. Contrastingly, in vitro and in vivo hemostatic evaluation models showed that C10-MPs thermally crosslinked for 5 h (C10 5 h) were the most suitable powder in terms of blood coagulation ability. Thus, C10 5 h has great potential for use in preventing post-ESD bleeding.
期刊介绍:
Biomaterials Advances, previously known as Materials Science and Engineering: C-Materials for Biological Applications (P-ISSN: 0928-4931, E-ISSN: 1873-0191). Includes topics at the interface of the biomedical sciences and materials engineering. These topics include:
• Bioinspired and biomimetic materials for medical applications
• Materials of biological origin for medical applications
• Materials for "active" medical applications
• Self-assembling and self-healing materials for medical applications
• "Smart" (i.e., stimulus-response) materials for medical applications
• Ceramic, metallic, polymeric, and composite materials for medical applications
• Materials for in vivo sensing
• Materials for in vivo imaging
• Materials for delivery of pharmacologic agents and vaccines
• Novel approaches for characterizing and modeling materials for medical applications
Manuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Materials Science and Engineering C. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.
Biomaterials Advances sits within Elsevier''s biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!